HealthPhoto: HT WorldBig Pharma Invests Billions in New Protein Degrader Drugs
After cancer treatments failed for Lisa Moore, she joined a study testing a new drug type called protein degraders, which target disease-causing proteins in a novel way. Ten months later, she went into remission. Major companies like Bristol Myers Squibb, Pfizer, and Roche are investing billions in these drugs, aiming to treat diseases from cancer to Parkinson’s by targeting hard-to-reach proteins involved in 85% of disease drivers.
HT World··Whately


